| Linagliptin, metformin |
EU/1/12/780/020 |
Jentadueto 2,5 mg/1000 mg, Film coated tablet, 2,5 mg/1000 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.62 |
13.12 |
78.74 |
4% |
2.62 |
68.24 |
13.65 |
81.89 |
16% |
10.5 |
78.74 |
15.75 |
94.49 |
|
НСР-2887/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2596 |
| Linagliptin, metformin |
EU/1/12/780/020 |
Jentadueto 2,5 mg/1000 mg, Film coated tablet, 2,5 mg/1000 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
69.82 |
13.96 |
83.78 |
4% |
2.79 |
72.61 |
14.52 |
87.13 |
16% |
11.17 |
83.78 |
16.76 |
100.54 |
|
HCР-150/13.06.2013 |
16.06.2013 |
16.06.2013 |
Неактивен |
2596 |
| Linagliptin, metformin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co. KG, Германия; Boehringer Ingelheim Ellas A.E., Гърция |
65.01 |
13 |
78.01 |
4% |
2.6 |
67.61 |
13.52 |
81.13 |
16% |
10.4 |
78.01 |
15.6 |
93.61 |
Корекционно решение НСР-13479/11.08.2017; Промяна на обстоятелства НСР-14215/19.10.2017 |
НСР-2887/05.03.2014; НСР-9113/27.04.2016; НСР-13279/20.07.2017 |
04.08.2017 |
02.12.2017 |
Неактивен |
2595 |
| Linagliptin, metformin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.01 |
13 |
78.01 |
4% |
2.6 |
67.61 |
13.52 |
81.13 |
16% |
10.4 |
78.01 |
15.6 |
93.61 |
Корекционно решение НСР-13479/11.08.2017 |
НСР-2887/05.03.2014; НСР-9113/27.04.2016; НСР-13279/20.07.2017 |
04.08.2017 |
02.09.2017 |
Неактивен |
2595 |
| Linagliptin, metformin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.54 |
13.11 |
78.65 |
4% |
2.62 |
68.16 |
13.63 |
81.79 |
16% |
10.49 |
78.65 |
15.73 |
94.38 |
|
НСР-2887/05.03.2014; НСР-9113/27.04.2016 |
02.06.2016 |
02.06.2016 |
Неактивен |
2595 |
| Linagliptin, metformin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.62 |
13.12 |
78.74 |
4% |
2.62 |
68.24 |
13.65 |
81.89 |
16% |
10.5 |
78.74 |
15.75 |
94.49 |
|
НСР-2887/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2595 |
| Linagliptin, metformin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
71.58 |
14.32 |
85.9 |
4% |
2.86 |
74.44 |
14.89 |
89.33 |
16% |
11.45 |
85.89 |
17.18 |
103.07 |
|
HCР-150/13.06.2013 |
16.06.2013 |
16.06.2013 |
Неактивен |
2595 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
6234.21 |
1246.84 |
7481.05 |
4% |
10 |
6244.21 |
1248.84 |
7493.05 |
16% |
25 |
6269.21 |
1253.84 |
7523.05 |
|
НСР-7772/28.12.2015; НСР-10434/29.09.2016; НСР-13281/20.07.2017 |
04.08.2017 |
02.09.2017 |
Активен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
6234.21 |
1246.84 |
7481.05 |
4% |
10 |
6244.21 |
1248.84 |
7493.05 |
16% |
25 |
6269.21 |
1253.84 |
7523.05 |
|
НСР-7772/28.12.2015; НСР-10434/29.09.2016; НСР-13281/20.07.2017 |
04.08.2017 |
02.09.2017 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7080.67 |
1416.13 |
8496.8 |
4% |
10 |
7090.67 |
1418.13 |
8508.8 |
16% |
25 |
7115.67 |
1423.13 |
8538.8 |
|
НСР-7772/28.12.2015; НСР-10434/29.09.2016 |
02.11.2016 |
02.11.2016 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7227.2 |
1445.44 |
8672.64 |
4% |
10 |
7237.2 |
1447.44 |
8684.64 |
16% |
25 |
7262.2 |
1452.44 |
8714.64 |
|
НСР-7772/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7275.04 |
1455.01 |
8730.05 |
4% |
10 |
7285.04 |
1457.01 |
8742.05 |
16% |
25 |
7310.04 |
1462.01 |
8772.05 |
корекционно решение НСР-7663/01.12.2015 |
НСР-5979/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7498.65 |
1499.73 |
8998.38 |
4% |
10 |
7508.65 |
1501.73 |
9010.38 |
16% |
25 |
7533.65 |
1506.73 |
9040.38 |
|
НСР-2530/24.01.2014 |
19.02.2014 |
19.02.2014 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7766.6 |
1553.32 |
9319.92 |
4% |
10 |
7776.6 |
1555.32 |
9331.92 |
16% |
25 |
7801.6 |
1560.32 |
9361.92 |
|
КЦРР-2619/15.03.2013 |
03.04.2013 |
03.04.2013 |
Неактивен |
3727 |
| Coagulation factor VIII (Damoctocog alfa pegol) |
EU/1/18/1324/002 |
Jivi, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial with powder + 1 pre-filled syringe with 2.5 ml solvent + 1 syringe plunger rod + 1 vial adapter + 1 venipuncture set |
Bayer AG, Германия |
Bayer AG, Germany |
762.77 |
152.55 |
915.32 |
4% |
10 |
772.77 |
154.55 |
927.32 |
16% |
25 |
797.77 |
159.55 |
957.32 |
|
НСР-19863/27.09.2019 |
12.10.2019 |
02.11.2019 |
Активен |
16728 |
| Coagulation factor VIII (Damoctocog alfa pegol) |
EU/1/18/1324/003 |
Jivi, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial with powder + 1 pre-filled syringe with 2.5 ml solvent + 1 syringe plunger rod + 1 vial adapter + 1 venipuncture set |
Bayer AG, Германия |
Bayer AG, Germany |
1525.55 |
305.11 |
1830.66 |
4% |
10 |
1535.55 |
307.11 |
1842.66 |
16% |
25 |
1560.55 |
312.11 |
1872.66 |
|
НСР-19863/27.09.2019 |
12.10.2019 |
02.11.2019 |
Активен |
16729 |
| Povidone- iodine |
20120205 |
JODASEPT KUPRO 10%, Ointment, 10% - 90 g, -, Pack: 1 |
Купро 94 ООД, България |
Купро 94 ООД, гр. Горна Оряховица, България |
5.77 |
1.15 |
6.92 |
7% |
0.4 |
6.17 |
1.23 |
7.4 |
20% |
1.15 |
7.32 |
1.46 |
8.78 |
|
НСР-7869/15.01.2016 |
02.02.2016 |
02.02.2016 |
Активен |
4175 |
| Povidone- iodine |
20120206 |
JODASEPT KUPRO 10% (w/w), cutaneous solution, 1000, ml, Pack: 1 |
Купро 94 ООД, България |
Купро 94 ООД, гр. Горна Оряховица, България |
9.99 |
2 |
11.99 |
7% |
0.7 |
10.69 |
2.14 |
12.83 |
20% |
2 |
12.69 |
2.54 |
15.23 |
|
НСР-7868/15.01.2016; НСР-19673/29.08.2019 |
13.09.2019 |
02.10.2019 |
Активен |
4174 |
| Povidone- iodine |
20120206 |
JODASEPT KUPRO 10% (w/w), cutaneous solution, 1000, ml, Pack: 1 |
Купро 94 ООД, България |
Купро 94 ООД, гр. Горна Оряховица, България |
9.74 |
1.95 |
11.69 |
7% |
0.68 |
10.42 |
2.08 |
12.5 |
20% |
1.95 |
12.37 |
2.47 |
14.84 |
|
НСР-7868/15.01.2016 |
02.02.2016 |
02.02.2016 |
Неактивен |
4174 |
| Povidone- iodine |
20120206 |
JODASEPT KUPRO 10% (w/w), cutaneous solution, 100, ml, Pack: 1 |
Купро 94 ООД, България |
Купро-94 ООД, Горна Оряховица |
1.95 |
0.39 |
2.34 |
7% |
0.14 |
2.09 |
0.42 |
2.51 |
20% |
0.39 |
2.48 |
0.5 |
2.98 |
корекционно решение НСР-9083/21.04.2016 |
НСР-8456/07.03.2016; НСР-15814/08.06.2018 |
23.06.2018 |
02.07.2018 |
Активен |
11508 |
| Povidone- iodine |
20120206 |
JODASEPT KUPRO 10% (w/w), cutaneous solution, 100, ml, Pack: 1 |
Купро 94 ООД, България |
Купро-94 ООД, Горна Оряховица |
2 |
0.4 |
2.4 |
7% |
0.14 |
2.14 |
0.43 |
2.57 |
20% |
0.4 |
2.54 |
0.51 |
3.05 |
корекционно решение НСР-9083/21.04.2016 |
НСР-8456/07.03.2016 |
02.04.2016 |
02.04.2016 |
Неактивен |
11508 |
| Povidone- iodine |
20120206 |
JODASEPT KUPRO 10% (w/w), cutaneous solution, 100, ml, Pack: 1 |
Купро 94 ООД, България |
Купро-94 ООД, Горна Оряховица |
2 |
0.4 |
2.4 |
7% |
0.14 |
2.14 |
0.43 |
2.57 |
20% |
0.4 |
2.54 |
0.51 |
3.05 |
|
НСР-8456/07.03.2016 |
02.04.2016 |
02.04.2016 |
Неактивен |
11508 |
| Dolutegravir, Rilpivirine |
EU/1/18/1282/001 |
Juluca, Film coated tablet, 50 mg/25 mg, -, Pack: 30 |
Viiv Healthcare BV, Нидерландия |
Glaxo Wellcome S.A., Испания |
1135.36 |
227.07 |
1362.43 |
4% |
10 |
1145.36 |
229.07 |
1374.43 |
16% |
25 |
1170.36 |
234.07 |
1404.43 |
|
НСР-20092/31.10.2019 предварително изпълнение; НСР-21599/04.06.2020 |
19.06.2020 |
02.07.2020 |
Активен |
16745 |
| Dolutegravir, Rilpivirine |
EU/1/18/1282/001 |
Juluca, Film coated tablet, 50 mg/25 mg, -, Pack: 30 |
Viiv Healthcare BV, Нидерландия |
Glaxo Wellcome S.A., Испания |
1261.51 |
252.3 |
1513.81 |
4% |
10 |
1271.51 |
254.3 |
1525.81 |
16% |
25 |
1296.51 |
259.3 |
1555.81 |
|
НСР-20092/31.10.2019 предварително изпълнение |
31.10.2019 |
02.11.2019 |
Неактивен |
16745 |
| Dolutegravir, Rilpivirine |
EU/1/18/1282/001 |
Juluca, Film coated tablet, 50 mg/25 mg, -, Pack: 30 |
Viiv Healthcare BV, Нидерландия |
Glaxo Wellcome S.A., Испания |
1261.51 |
252.3 |
1513.81 |
4% |
10 |
1271.51 |
254.3 |
1525.81 |
16% |
25 |
1296.51 |
259.3 |
1555.81 |
|
НСР-20092/31.10.2019 предварително изпълнение |
31.10.2019 |
02.11.2019 |
Неактивен |
16745 |